SK
AVEO

Seth Klarman’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Seth Klarman’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-382,935
Closed -$4.25M – 29
2014
Q3 		$4.25M Hold
382,935
– – 0.07% 27
2014
Q2 		$7.01M Hold
382,935
– – 0.11% 22
2014
Q1 		$5.72M Hold
382,935
– – 0.14% 19
2013
Q4 		$7.01M Hold
382,935
– – 0.2% 17
2013
Q3 		$7.89M Hold
382,935
– – 0.23% 20
2013
Q2 		$9.57M Buy
+382,935
New +$16.4M 0.24% 22

Other funds holding AVEO

SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DVC
Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
GX
Greylock XI Cambridge, Massachusetts $7.71M AUM 28.23% 1-Year Est. Return

Seth Klarman's AVEO Position: Q4 2014 in Review

Seth Klarman sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2014, closing a stake of 382,935 shares — an estimated $4.25M sold.

Seth Klarman first reported a position in AVEO in Q2 2013 and held it in 6 quarters. The position peaked at $9.57M in Q2 2013. 51 funds tracked by Wall St. Rank hold AVEO as of Q4 2014.

  • Seth Klarman reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Seth Klarman sold 382,935 AVEO Pharmaceuticals, Inc. shares in Q4 2014, an estimated $4.25M.
  • Seth Klarman first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 6 quarters.
  • Seth Klarman's AVEO Pharmaceuticals, Inc. position peaked at $9.57M in Q2 2013.
  • 51 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2014.

Based on Baupost Group's 13F filing for Q4 2014, filed 13 Feb 2015.